ACADIA Pharmaceuticals, Inc. to Announce Fourth Quarter and Full Year 2012 Financial Results on March 12, 2013

ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD), a biopharmaceutical company focused on innovative treatments that address unmet medical needs in neurological and related central nervous system disorders, today announced that it will report its financial results for the fourth quarter and year ended December 31, 2012 on Tuesday, March 12, 2013, after the U.S. financial markets close. ACADIA's management will host a conference call and webcast on Tuesday, March 12, 2013, at 5:00 p.m. Eastern Time to discuss ACADIA’s financial results and development programs.